Suppr超能文献

胸痛患者中高敏肌钙蛋白I检测——与伴或不伴肾衰竭的显著冠状动脉病变的关联

Sensitive Troponin I Assay in Patients with Chest Pain - Association with Significant Coronary Lesions with or Without Renal Failure.

作者信息

Soeiro Alexandre de Matos, Gualandro Danielle Menosi, Bossa Aline Siqueira, Zullino Cindel Nogueira, Biselli Bruno, Soeiro Maria Carolina Feres de Almeida, Leal Tatiana de Carvalho Andreucci Torres, Serrano Carlos Vicente, Oliveira Junior Mucio Tavares de

机构信息

Unidade Clínica de Emergência - InCor - HCFMUSP, São Paulo, SP - Brazil.

出版信息

Arq Bras Cardiol. 2018 Jan;110(1):68-73. doi: 10.5935/abc.20170182.

Abstract

INTRODUCTION

Despite having higher sensitivity as compared to conventional troponins, sensitive troponins have lower specificity, mainly in patients with renal failure.

OBJECTIVE

Study aimed at assessing the sensitive troponin I levels in patients with chest pain, and relating them to the existence of significant coronary lesions.

METHODS

Retrospective, single-center, observational. This study included 991 patients divided into two groups: with (N = 681) and without (N = 310) significant coronary lesion. For posterior analysis, the patients were divided into two other groups: with (N = 184) and without (N = 807) chronic renal failure. The commercial ADVIA Centaur® TnI-Ultra assay (Siemens Healthcare Diagnostics) was used. The ROC curve analysis was performed to identify the sensitivity and specificity of the best cutoff point of troponin as a discriminator of the probability of significant coronary lesion. The associations were considered significant when p < 0.05.

RESULTS

The median age was 63 years, and 52% of the patients were of the male sex. The area under the ROC curve between the troponin levels and significant coronary lesions was 0.685 (95% CI: 0.65 - 0.72). In patients with or without renal failure, the areas under the ROC curve were 0.703 (95% CI: 0.66 - 0.74) and 0.608 (95% CI: 0.52 - 0.70), respectively. The best cutoff points to discriminate the presence of significant coronary lesion were: in the general population, 0.605 ng/dL (sensitivity, 63.4%; specificity, 67%); in patients without renal failure, 0.605 ng/dL (sensitivity, 62.7%; specificity, 71%); and in patients with chronic renal failure, 0.515 ng/dL (sensitivity, 80.6%; specificity, 42%).

CONCLUSION

In patients with chest pain, sensitive troponin I showed a good correlation with significant coronary lesions when its level was greater than 0.605 ng/dL. In patients with chronic renal failure, a significant decrease in specificity was observed in the correlation of troponin levels and severe coronary lesions.

摘要

引言

尽管与传统肌钙蛋白相比,敏感肌钙蛋白具有更高的敏感性,但特异性较低,主要是在肾衰竭患者中。

目的

本研究旨在评估胸痛患者的敏感肌钙蛋白I水平,并将其与显著冠状动脉病变的存在相关联。

方法

回顾性、单中心、观察性研究。本研究纳入991例患者,分为两组:有显著冠状动脉病变组(N = 681)和无显著冠状动脉病变组(N = 310)。为进行后续分析,患者又被分为另外两组:有慢性肾衰竭组(N = 184)和无慢性肾衰竭组(N = 807)。使用了商业ADVIA Centaur® TnI-Ultra检测法(西门子医疗诊断公司)。进行ROC曲线分析以确定肌钙蛋白最佳截断点作为显著冠状动脉病变可能性判别指标的敏感性和特异性。当p < 0.05时,认为关联具有显著性。

结果

中位年龄为63岁,52%的患者为男性。肌钙蛋白水平与显著冠状动脉病变之间的ROC曲线下面积为0.685(95%CI:0.65 - 0.72)。在有或无肾衰竭的患者中,ROC曲线下面积分别为0.703(95%CI:0.66 - 0.74)和0.608(95%CI:0.52 - 0.70)。判别显著冠状动脉病变存在的最佳截断点为:在总体人群中,0.605 ng/dL(敏感性,63.4%;特异性,67%);在无肾衰竭患者中,0.605 ng/dL(敏感性, 62.7%;特异性,71%);在慢性肾衰竭患者中,0.515 ng/dL(敏感性,80.6%;特异性,42%)。

结论

在胸痛患者中,当敏感肌钙蛋白I水平大于0.605 ng/dL时,其与显著冠状动脉病变显示出良好的相关性。在慢性肾衰竭患者中,观察到肌钙蛋白水平与严重冠状动脉病变的相关性中特异性显著降低。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22c5/5831304/309f3cd208f3/abc-110-01-0068-g01.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验